Recombinant expression, purification and characterization of human soluble tumor necrosis factor receptor 2.


Journal

Protein expression and purification
ISSN: 1096-0279
Titre abrégé: Protein Expr Purif
Pays: United States
ID NLM: 9101496

Informations de publication

Date de publication:
06 2021
Historique:
received: 26 12 2020
revised: 13 02 2021
accepted: 20 02 2021
pubmed: 28 2 2021
medline: 25 12 2021
entrez: 27 2 2021
Statut: ppublish

Résumé

TNFR2 is aberrantly expressed on various cancer cells and highly immunosuppressive regulatory T cells (T

Identifiants

pubmed: 33639277
pii: S1046-5928(21)00040-1
doi: 10.1016/j.pep.2021.105857
pii:
doi:

Substances chimiques

Receptors, Tumor Necrosis Factor, Type II 0
Recombinant Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105857

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

An Li (A)

School of Pharmacy, Second Military Medical University, Shanghai, 200433, China; Department of Critical Care Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China.

Kuo Sun (K)

School of Pharmacy, Second Military Medical University, Shanghai, 200433, China.

Junjie Wang (J)

Department of Critical Care Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China.

Shuocun Wang (S)

School of Medicine, Shanghai University, Shanghai, 200444, China.

Xin Zhao (X)

Department of Critical Care Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China.

Runhui Liu (R)

School of Pharmacy, Second Military Medical University, Shanghai, 200433, China. Electronic address: lyliurh@126.com.

Yiming Lu (Y)

School of Pharmacy, Second Military Medical University, Shanghai, 200433, China; Department of Critical Care Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China; School of Medicine, Shanghai University, Shanghai, 200444, China. Electronic address: bluesluyi@sina.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH